Phargentis Gets European Partner For Fostair Rival

Swiss respiratory specialist Phargentis has struck a deal with “one of Europe’s leading generic pharma companies” for commercial rights to its proposed rival to Chiesi’s Fostair (beclomethasone/formoterol) respiratory brand.